Quantass ApS CEO

Roles

SynAct Pharma AB Stockholm
CEO
17.12.202517.12.2025

Transactions (including via associated entities)

DateIssuerNatureVolumePriceValueSource
17.12.2025SynAct Pharma AB Stockholm
Bought — open marketAcquisition
3,529SEK 20.24
SEK 71,429.32